Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.53 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10766533 | 1.00 | POLB (0.80) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL4704495 | 1.00 | POLB (0.80) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL1884524 | 0.98 | POLB (0.83) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL856769 | 0.93 | POLB (0.79) | POLBNPC1RAB9AMAPTKDM4E | |
| SCHEMBL29505763 | 0.93 | POLB (0.79) | POLBNPC1RAB9AMAPTKDM4E | |
| Hydrochloric Acid SCHEMBL8327038 | 0.92 | POLB (0.77) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL30701863 | 0.91 | POLB (0.96) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL7854826 | 0.91 | POLB (0.96) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL7856315 | 0.91 | POLB (0.96) | POLBNPC1RAB9AMAPTPKM | |
| SCHEMBL7856311 | 0.91 | POLB (0.96) | POLBNPC1RAB9AMAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060142167-A1 | Water-soluble copper, copper alloys and non-ferrous metals intermediate cold and hot rolling composition | PRINCE FRANCIS | 2006-06-29 | — | — | US | claimed |
| EP-1257624-B1 | WATER-SOLUBLE COPPER, COPPER ALLOYS AND NON-FERROUS METALS INTERMEDIATE COLD AND HOT ROLLING COMPOSITION | MOBIL OIL FRANCE (FR) | 2004-10-06 | — | — | EP | claimed |
| US-20040168748-A1 | Addition product, production and use thereof as corrosion inhibitor | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-09-02 | — | — | US | claimed |
| EP-1373599-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002090619-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-11-14 | — | — | WO | claimed |
| EP-1123971-A1 | Water-soluble copper, copper alloys and non-ferrous metals intermediate cold and hot rolling composition | Mobil Oil Francaise (FR) | 2001-08-16 | — | — | EP | claimed |
| EP-0226016-A1 | Process for inhibiting hydrogen-induced corrosion of metallic materials | BAYER AG (DE) | 1987-06-24 | — | — | EP | claimed |
| US-4026815-A | ADDING A PHOSPHONOCARBOXYLIC ACID AND A BENZIMIDAZOLE DERIVATIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-31 | — | — | US | claimed |
| US-4000079-A | ANTIFREEZE ADDITIVES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | claimed |
| CN-106350678-B | A method of recycling corrosion inhibiter and copper from brown oxide waste liquid | 盛隆资源再生（无锡）有限公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-106245058-B | A kind of method of copper in electrolytic recovery brown oxide waste liquid | 盛隆资源再生（无锡）有限公司 | 2018-06-19 | — | — | CN | disclosed |
| WO-2018025872-A1 | LIQUID CRYSTAL DISPLAY ELEMENT EQUIPPED WITH LIQUID CRYSTAL PANEL HAVING CURVED SURFACE AND LIQUID CRYSTAL ALIGNING AGENT FOR SAME | 日産化学工業株式会社 | 2018-02-08 | — | — | WO | disclosed |
| US-20170313708-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | FELIQS CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| WO-2012014898-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2012-02-02 | — | — | WO | disclosed |
| US-4104194-A | 1,2-FUSED 5- OR 6-MEMBERED 1,3-DINITROGEN HETEROCYCLIC COMPOUNDS AS ANTICORROSION AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-01 | — | — | US | disclosed |
| US-4094811-A | REDUCING SILVER SALTS IN THE PRESENCE OF A HETEROCYCLIC 5- OR 6-MEMBERED NITROGEN COMPOUND | AGFA-GEVAERT AKTIENGESELLSCHAFT (DT) | 1978-06-13 | — | — | US | disclosed |
| US-4048174-A | ANTI-CORROSION AGENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-13 | — | — | US | disclosed |
| US-4026815-A | ADDING A PHOSPHONOCARBOXYLIC ACID AND A BENZIMIDAZOLE DERIVATIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-31 | — | — | US | disclosed |
| US-4000079-A | ANTIFREEZE ADDITIVES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3972890-A | ACID CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170313708-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | FFAR3, FFAR2, FFAR1 | POLB 4074/4885NPC1 647/4885RAB9A 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.